Hypotensive activity of aqueous extract of Andrographis paniculata in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages 675-678

  Zhang, C Y ^a   Tan, Bkh ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Andrographis paniculata; Angiotensin converting enzyme; Lipid peroxidation; Spontaneously hypertensive rat; Systolic blood pressure; Wistar Kyoto rat

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FREE RADICAL; PLANT EXTRACT;

ANDROGRAPHIS PANICULATA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANDROGRAPHIS PANICULATA;

EID: 0029852445     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01756.x     Document Type: Article

References (26)

1. Tang W, Eisenbrand G. Chinese Drugs of Plant Origin. SpringerVerlag, Berlin. 1992.
2. Ahmad M, Asmawi MZ. Some pharmacological effects of aqueous extract of Andrographis paniculata Nées. In: Gan EK. (ed). The International Conference on the Use of Traditional Medicine & Other Natural Products in Health-Care. 8-11 June 1993; Malaysia: School of Pharmaceutical Sciences, University of Science Malaysia, 1993: 122 (Abstract).
3. Yeung SCS, Yao SC, Wang LL. Pharmacology and Applications of Chinese Materia Medico, vol. 2. World Scientific Publishing Co. Pte Ltd, Singapore. 1987.
4. Handa SS, Sharma A. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride. Indian J. Med. Res. 1990; 92: 284-92.
5. Akbarsha MA, Manivannan B, Hamid KS, Vijayan B. Antifertility effect of Andrographis paniculata (Nées) in male albino rat. Indian J. Exp. Biol. 1990; 28: 421-6.
6. Zhu PV, Liu GQ. Separation and identification of flavonoids in Andrographis paniculata Nées leaves. Chin. Trad. Herb Drugs 1984; 15: 375-6.
7. Kuroyanagi M, Sato M, Ueno A, Nishi K. Flavonoids from Andrographis paniculata. Chem. Pharm. Bull. 1987; 35:4429-35.
8. Yamori Y. Neural and non-neural mechanisms in spontaneous hypertension. Clin. Sci. Mol. Med. 1976; 51: S431-4.
9. Yugarani T, Tan BKH, Das NP. The effects of tannic acid on serum lipid parameters and tissue lipid peroxides in the spontaneously hypertensive and Wistar-Kyoto rats. Planta Medico I993;59:28-31.
10. Das UN, Ramesh G, Suryaprabha P et al. Free radical theory of human essential hypertension. In: Miyai K, Kanno T, Ishikawa E (eds). Progress in Clinical Biochemistry. Ireland: Elsevier Science Publishers BV. 1992; pp. 889-900.
11. Soffer RL. Angiotensin I converting enzyme and the regulation of vasoactive peptides. Ann. Revu. Biochem. 1976; 45: 73-94.
12. Sim MK, Chua ME. Angiotensin converting enzyme activity in strains of normo- and hypertensive rats. Clin. Exp. Hypertens. 1987; 49: 1763-70.
13. Mendelsohn FAO, Hutchinson JS, Csicsmann J. Angiotensin converting enzyme in the brain of spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1980; 7: 551-4.
14. Bunag RD. Validation in awake rats of a tail-cuff method of measuring systolic pressure. J. Appl. Phys. 1973; 34: 279-81.
15. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978; 86:271-8.
16. Skeggs LT, Kahn JR, Shumway NP. The preparation and function of the angiotensin-converting enzyme. J. Exp. Med. 1956; 103: 295-9.
17. Roth M, Weitzman AF, Piquilloud Y. Converting enzyme content of different tissues of the rat. Experientia 1969; 25: 1247.
18. Cushman DW, Cheung HS. Studies in vitro of angiotensinconverting enzyme of lung and other tissues. In: Genest J, Koiw E (eds). Hypertension. Springer, Berlin. 1972; pp. 532-41.
19. Antonaccio MJ (ed.). Cardiovascular Pharmacology, 3rd edn. Raven Press, New York. 1990.
20. Cohen ML, Kurz KD. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J. Pharmacol. Exp. Ther. 1982; 220: 63-9.
21. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
22. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH. The nature of endothelium-derived vascular relaxing factor. Nature 1984; 308: 645-7.
23. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320:454-6.
24. Suryaprabha P, Das UN, Koratkar R, Sangeetha Sagar P, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot. Essenl. Fatty Acids 1990; 41: 27-33.
25. Ikemoto F, Song GB, Tominaga M, Yamamoto K. Oxidation induced increase in activity of angiotensin converting enzyme in the rat kidney. Biochem. Biophys. Res. Commun. 1988; 153: 1032-7.
26. Bagchi D, Prasad R, Das DK. Direct scavenging effect of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem. Biophys. Res. Commun. 1989; 158: 52-7.